Cardiovascular Devices Market by Product (Cardiac Imaging, Rhythm Management, Cardiac Assist Devices, Interventional Cardiology, Electrophysiology, Monitoring), Indication (CAD, MI, CHF), End User (Hospitals & Clinics) - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Segmentation
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Growth Forecast
2.4 Market Breakdown & Data Triangulation
2.5 Market Ranking Analysis
2.6 Study Assumptions
2.7 Research Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations
2.8 Risk Assessment

4.1 Cardiovascular Devices Market Overview
4.2 North America: Cardiovascular Devices Market, by End-user and Country (2023)
4.3 Cardiovascular Devices Market: Regional Mix, 2024-2029 (USD Million)

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Cardiovascular Diseases
5.2.1.2 Increasing Accessibility to Advanced High-Performance Devices
5.2.1.3 Growing Preference for Minimally Invasive Surgeries
5.2.1.4 Rising Technological Advancements in Cardiovascular Devices
5.2.1.5 Increasing Trend of Remote Patient Monitoring
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Guidelines for Product Approval
5.2.2.2 Shortage of Skilled Cardiac Health Professionals
5.2.3 Opportunities
5.2.3.1 Rising Geriatric Population and Increasing Uptake of Cvd Devices
5.2.3.2 Emergence of Biodegradable Cardiovascular Devices
5.2.4 Challenges
5.2.4.1 Product Recalls & Failures
5.2.4.2 Complications Associated with Implantable Devices
5.3 Industry Trends
5.3.1 Minimally Invasive Procedures
5.3.2 Wearable Technology and Remote Monitoring
5.3.3 Personalized Medicine
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 Transcatheter Aortic Valve Replacement (Tavr)
5.4.1.2 Cardiac Mapping Systems
5.4.1.3 3D-Printed Cardiovascular Devices
5.4.2 Complementary Technologies
5.4.2.1 Robotic-Assisted Surgeries
5.4.2.2 Advanced Catheter Systems
5.4.2.3 Imaging Technologies
5.4.3 Adjacent Technologies
5.4.3.1 Regenerative Medicine
5.4.3.2 Biomaterials & Nanotechnology
5.4.3.3 Big Data & Cloud Computing
5.5 Porter's Five Force Analysis
5.5.1 Threat of New Entrants
5.5.2 Bargaining Power of Suppliers
5.5.3 Bargaining Power of Buyers
5.5.4 Threat of Substitutes
5.5.5 Intensity of Competitive Rivalry
5.6 Regulatory Landscape
5.6.1 Regulatory Analysis
5.6.1.1 North America
5.6.1.1.1 US
5.6.1.1.2 Canada
5.6.1.2 Europe
5.6.1.3 Asia-Pacific
5.6.1.4 Latin America
5.6.1.5 Middle East & Africa
5.6.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.7 Patent Analysis
5.7.1 Patent Publication Trends in Cardiovascular Devices Market
5.7.2 Insights: Jurisdiction and Top Applicant Analysis
5.8 Trade Analysis
5.9 Pricing Analysis
5.10 Key Conferences & Events, 2024-2025
5.11 Key Stakeholders and Buying Criteria
5.11.1 Key Stakeholders in Buying Process
5.11.2 Buying Criteria
5.12 Unmet Needs/End-user Expectations in Cardiovascular Devices Market
5.13 Impact of AI/Generative AI on Cardiovascular Devices Market
5.14 Ecosystem Analysis
5.15 Case Study Analysis
5.15.1 Case Study 1: Evaluation of Tavr System
5.15.2 Case Study 2: Safety & Efficacy Assessment of Watchman Device in Atrial Fibrillation
5.15.3 Case Study 3: Performance Analysis of Mitraclip for the Treatment of Mitral Regurgitation
5.16 Supply Chain Analysis
5.17 Adjacent Market Analysis
5.17.1 Cardiac Monitoring and Rhythm Management Devices Market
5.18 Trends/Disruptions Impacting Customers’ Businesses
5.19 Cardiovascular Devices Market: Investment & Funding Scenario
5.20 R&D Pipeline Analysis

6.1 Introduction
6.2 Cardiac Imaging & Diagnostic Devices
6.2.1 ECG Devices
6.2.1.1 Low Costs and Expanding Applications to Fuel Market
6.2.2 Cardiac Ultrasound Imaging
6.2.2.1 Growing Preference Towards Minimally Invasive Techniques to Boost Demand
6.2.3 Cardiac Computerized Tomography (CT) Scanners
6.2.3.1 Increasing Preference Over Other Diagnostic Imaging Methods to Drive Market
6.2.4 Cardiac Magnetic Resonance Imaging (MRI)
6.2.4.1 Increasing Incidence of Cardiac Diseases to Fuel Uptake
6.2.5 Nuclear Cardiology Systems
6.2.5.1 Ability to Assess Tissue Functionality and Heart Physiology to Support Market Growth
6.2.6 Cardiac Diagnostic Catheters
6.2.6.1 Rising Focus on Catheterization Procedures to Fuel Market
6.3 Cardiac Rhythm Management Devices
6.3.1 Pacemakers
6.3.1.1 Growing Availability of Leadless and MRI-Safe Devices to Boost Demand
6.3.2 Implantable Cardioverter Defibrillators (Icd)
6.3.2.1 Increasing Prevalence of Arrhythmias to Drive Market
6.3.3 Cardiac Resynchronization Therapy (Crt) Devices
6.3.3.1 Ability to Reduce Fatigue and Associated Heart Failure Symptoms to Boost Demand
6.4 Interventional Cardiology Devices
6.4.1 Coronary Stents
6.4.1.1 Technological Advancements in Stents to Fuel Uptake
6.4.2 Heart Valve Devices
6.4.2.1 Increasing Prevalence of Valve Stenosis and Regurgitation to Fuel Market
6.4.3 Closure Devices
6.4.3.1 Utilization of Self-Expandable Materials to Drive Market
6.4.4 Surgical Catheters
6.4.4.1 Rising Adoption of Angioplasty Procedures to Support Market Growth
6.4.5 Guidewires
6.4.5.1 Rising Uptake in Pci Procedures to Drive Market
6.4.6 Other Interventional Cardiology Devices
6.5 Cardiac Assist Devices
6.5.1 Ventricular Assist Devices
6.5.1.1 Rising Incidence of Heart Failure to Boost Market
6.5.2 Intra-Aortic Balloon Pumps (Iabp)
6.5.2.1 Product Recalls to Restrain Market
6.5.3 Total Artificial Heart (Tah)
6.5.3.1 Growing Product Pipeline to Fuel Market
6.5.4 Impella Devices
6.5.4.1 Increasing Utility in High-Risk Procedures to Support Market Growth
6.6 Electrophysiology Devices
6.6.1 Ep Catheters
6.6.1.1 Rising Incidence of Chronic Heart Conditions to Drive Market
6.6.2 Ablation Systems
6.6.2.1 Increasing Utilization of Radiofrequency Ablation Procedures to Support Market Growth
6.6.3 3D Mapping System
6.6.3.1 Development of Alternative Technologies to Hinder Market
6.7 External Support Devices
6.7.1 External Defibrillators
6.7.1.1 Adoption of User-Friendly Aeds to Fuel Market
6.7.2 External Pacemakers
6.7.2.1 Technological Advancements in Leadless & Implantable Pacemakers to Restrain Market
6.7.3 Cardiac Compression Devices
6.7.3.1 Reduced Cpr Rate to Restrain Market
6.8 Monitoring Devices
6.8.1 Blood Pressure Monitors
6.8.1.1 Portability and Ease of Use to Fuel Market
6.8.2 Pulse Oximeters
6.8.2.1 Increasing Adoption of OTC Devices in Home Care Settings to Propel Market
6.8.3 Implantable Cardiac Monitors (Icm)
6.8.3.1 Growing Focus on Rpm to Support Market

7.1 Introduction
7.2 Coronary Artery Disease
7.2.1 Angina Pectoris
7.2.1.1 Growing Adoption of Implantable Monitors and ECG Devices for Treatment to Drive Market
7.2.2 Myocardial Infarction
7.2.2.1 Increasing Demand for Stents in Acute Cases to Fuel Market
7.3 Arrhythmias
7.3.1 Tachycardia
7.3.1.1 Rising Cardiac Electrophysiology Procedures to Drive Market
7.3.2 Bradycardia
7.3.2.1 Rising Incidence of Osa to Support Market Growth
7.4 Structural Heart Disease
7.4.1 Valvular Heart Disease
7.4.1.1 Rising Risks of Aortic Stenosis to Drive Market
7.4.2 Congenital Heart Disease
7.4.2.1 Potential for New Therapies to Fuel Uptake
7.4.3 Cardiomyopathy
7.4.3.1 Uptake of Icds to Drive Market
7.4.4 Congestive Heart Failure
7.4.4.1 Growth in Geriatric Population to Fuel Market
7.5 Inflammatory Heart Disease
7.5.1 Pericarditis
7.5.1.1 Increasing Incidence due to COVID-19 to Support Market Growth
7.5.2 Myocarditis
7.5.2.1 Increasing Prevalence of Autoimmune Diseases to Support Market Growth
7.5.3 Endocarditis
7.5.3.1 Focus on Echocardiography for Clinical Evaluation to Drive Market
7.6 Other Cardiovascular Indications

8.1 Introduction
8.2 Hospitals & Clincs
8.2.1 High Purchasing Power of Hospitals and Rising Number of Cardiovascular Procedures to Drive Market
8.3 Diagnostic Laboratories
8.3.1 Rising Focus on Technologically Advanced Diagnostic Instruments to Support Market Growth
8.4 Ambulatory Surgery Centers
8.4.1 Increasing Demand for Outpatient Care and Rpm Services to Propel Market
8.5 Other End-users

9.1 Introduction
9.2 North America
9.2.1 Macroeconomic Outlook for North America
9.2.2 US
9.2.2.1 Increasing Cases of Obesity due to Sedentary Lifestyles to Propel Market
9.2.3 Canada
9.2.3.1 Increasing Funding for Cvd Research to Support Market Growth
9.3 Europe
9.3.1 Increasing Product Approvals for Advanced Cardiovascular Devices to Drive Market
9.3.2 Macroeconomic Outlook for Europe
9.4 Asia-Pacific
9.4.1 Large Target Patient Population and Increasing Incidence of Cvd to Propel Market
9.4.2 Macroeconomic Outlook for Asia-Pacific
9.5 Latin America
9.5.1 Burden of Congenital Heart Diseases to Drive Market
9.5.2 Macroeconomic Outlook for Latin America
9.6 Middle East & Africa
9.6.1 Rising Healthcare Expenditure to Support Market Growth
9.6.2 Macroeconomic Outlook for Middle East & Africa

10.1 Overview
10.2 Key Player Strategies/Right to Win
10.2.1 Overview of Strategies Adopted by Players in Cardiovascular Devices Market
10.3 Revenue Analysis
10.4 Market Share Analysis
10.4.1 Ranking of Key Market Players, 2023
10.5 Company Evaluation Matrix: Key Players, 2023
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
10.5.5 Company Footprint: Key Players, 2023
10.5.5.1 Company Footprint
10.5.5.2 Region Footprint
10.5.5.3 Product Footprint
10.5.5.4 Indication Footprint
10.5.5.5 End-user Footprint
10.6 Company Evaluation Matrix: Startups/SMEs, 2023
10.6.1 Progressive Companies
10.6.2 Responsive Companies
10.6.3 Dynamic Companies
10.6.4 Starting Blocks
10.6.5 Competitive Benchmarking: Startups/SMEs, 2023
10.7 Company Valuation & Financial Metrics
10.7.1 Company Valuation
10.7.2 Financial Metrics
10.8 Brand/Product Comparison
10.9 Competitive Scenario
10.9.1 Product Launches & Approvals
10.9.2 Deals
10.9.3 Expansions
10.9.4 Other Developments

11.1 Key Players
11.1.1 Medtronic
11.1.1.1 Business Overview
11.1.1.2 Products Offered
11.1.1.3 Recent Developments
11.1.1.3.1 Product Launches & Approvals
11.1.1.3.2 Deals
11.1.1.4 Analyst's View
11.1.1.4.1 Key Strengths
11.1.1.4.2 Strategic Choices
11.1.1.4.3 Weaknesses & Competitive Threats
11.1.2 Abbott Laboratories
11.1.2.1 Business Overview
11.1.2.2 Products Offered
11.1.2.3 Recent Developments
11.1.2.3.1 Product Launches & Approvals
11.1.2.3.2 Deals
11.1.2.4 Analyst's View
11.1.2.4.1 Key Strengths
11.1.2.4.2 Strategic Choices
11.1.2.4.3 Weaknesses & Competitive Threats
11.1.3 Boston Scientific Corporation
11.1.3.1 Business Overview
11.1.3.2 Products Offered
11.1.3.3 Recent Developments
11.1.3.3.1 Product Launches & Approvals
11.1.3.3.2 Deals
11.1.3.4 Analyst's View
11.1.3.4.1 Key Strengths
11.1.3.4.2 Strategic Choices
11.1.3.4.3 Weaknesses & Competitive Threats
11.1.4 GE Healthcare
11.1.4.1 Business Overview
11.1.4.2 Products Offered
11.1.4.3 Recent Developments
11.1.4.3.1 Product Launches & Approvals
11.1.4.3.2 Deals
11.1.4.4 Analyst's View
11.1.4.4.1 Key Strengths
11.1.4.4.2 Strategic Choices
11.1.4.4.3 Weaknesses & Competitive Threats
11.1.5 Terumo Corporation
11.1.5.1 Business Overview
11.1.5.2 Products Offered
11.1.5.3 Recent Developments
11.1.5.3.1 Product Launches & Approvals
11.1.5.4 Analyst's View
11.1.5.4.1 Key Strengths
11.1.5.4.2 Strategic Choices
11.1.5.4.3 Weaknesses & Competitive Threats
11.1.6 Edwards Lifesciences Corporation
11.1.6.1 Business Overview
11.1.6.2 Products Offered
11.1.6.3 Recent Developments
11.1.6.3.1 Product Launches & Approvals
11.1.6.3.2 Deals
11.1.7 Siemens Healthineers AG
11.1.7.1 Business Overview
11.1.7.2 Products Offered
11.1.7.3 Recent Developments
11.1.7.3.1 Product Launches & Approvals
11.1.8 Johnson and Johnson Services, Inc.
11.1.8.1 Business Overview
11.1.8.2 Products Offered
11.1.8.3 Recent Developments
11.1.8.3.1 Product Launches & Approvals
11.1.8.3.2 Deals
11.1.9 Sahajanand Medical Technologies Limited
11.1.9.1 Business Overview
11.1.9.2 Products Offered
11.1.10 Baxter International Inc
11.1.10.1 Business Overview
11.1.10.2 Products Offered
11.1.10.3 Recent Developments
11.1.10.3.1 Deals
11.1.11 Artivion, Inc.
11.1.11.1 Business Overview
11.1.11.2 Products Offered
11.1.12 Getinge Ab
11.1.12.1 Business Overview
11.1.12.2 Products Offered
11.1.12.3 Recent Developments
11.1.12.3.1 Product Launches & Approvals
11.1.12.3.2 Deals
11.1.13 Koninklijke Philips N.V.
11.1.13.1 Business Overview
11.1.13.2 Products Offered
11.1.13.3 Recent Developments
11.1.13.3.1 Product Launches & Approvals
11.1.14 Nihon Kohden Corporation
11.1.14.1 Business Overview
11.1.14.2 Products Offered
11.1.15 Biotronik SE & Co.KG.
11.1.15.1 Business Overview
11.1.15.2 Products Offered
11.1.16 Lepu Medical Technology(Beijing) Co. Ltd.
11.1.16.1 Business Overview
11.1.16.2 Products Offered
11.1.16.3 Recent Developments
11.1.16.3.1 Product Launches & Approvals
11.1.17 Microport Scientific Corporation
11.1.17.1 Business Overview
11.1.17.2 Products Offered
11.1.17.3 Recent Developments
11.1.17.3.1 Product Launches & Approvals
11.1.18 Angiodynamics Inc.
11.1.18.1 Business Overview
11.1.18.2 Products Offered
11.1.19 Japan Lifeline Co. Ltd.
11.1.19.1 Business Overview
11.1.19.2 Products Offered
11.1.19.3 Recent Developments
11.1.19.3.1 Product Launches & Approvals
11.1.20 W.L. Gore & Associates
11.1.20.1 Business Overview
11.1.20.2 Products Offered
11.1.21 B. Braun SE
11.1.21.1 Business Overview
11.1.21.2 Products Offered
11.2 Other Players
11.2.1 Canon Medical Systems Corporation
11.2.2 Picard Medical Company
11.2.3 Bpl Medical Technologies Pvt Ltd
11.2.4 Lifetech Scientific Corporation
11.2.5 Orbusneich Medical Group Holdings Limited

12.1 Discussion Guide
12.2 Knowledgestore: The Subscription Portal
12.3 Customization Options

Table 1 Currency Conversion Rates
Table 2 Cardiovascular Devices Market: Study Assumptions
Table 3 Cardiovascular Devices Market: Risk Assessment Analysis
Table 4 Potential Adverse Effects Associated with Different Devices
Table 5 Porter's Five Forces Analysis
Table 6 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 List of Patents in Cardiovascular Devices Market, 2014-2024
Table 12 Import Data for Cardiovascular Devices Market, by Country, 2018-2023 (USD Million)
Table 13 Export Data for Cardiovascular Devices, by Country, 2018-2023 (USD Million)
Table 14 Cardiovascular Devices Market: Average Selling Price, by Product (2023)
Table 15 Average Selling Price Trend of Cardiovascular Devices, by Region (2023)
Table 16 Cardiovascular Devices Market: Key Conferences & Events, 2024-2025
Table 17 Influence of Stakeholders on Buying Process for Top 3 End-users
Table 18 Key Buying Criteria for Top 3 End-users of Cardiovascular Devices
Table 19 Cardiovascular Devices Market: Unmet Needs
Table 20 Cardiovascular Devices Market: End-user Expectations
Table 21 Cardiovascular Devices Market: Impact of AI/Generative AI
Table 22 Cardiovascular Devices Market: Ecosystem Analysis
Table 23 Cardiovascular Devices Market: R&D Pipeline Analysis
Table 24 Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 25 Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 26 Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 27 Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 28 Cardiac Imaging & Diagnostic Devices Market, by Region, 2021-2023 (USD Million)
Table 29 Cardiac Imaging & Diagnostic Devices Market, by Region, 2024-2029 (USD Million)
Table 30 ECG Devices Market, by Region, 2021-2023 (USD Million)
Table 31 ECG Devices Market, by Region, 2024-2029 (USD Million)
Table 32 Cardiac Ultrasound Imaging Market, by Region, 2021-2023 (USD Million)
Table 33 Cardiac Ultrasound Imaging Market, by Region, 2024-2029 (USD Million)
Table 34 Cardiac CT Scanners Market, by Region, 2021-2023 (USD Million)
Table 35 Cardiac CT Scanners Market, by Region, 2024-2029 (USD Million)
Table 36 Cardiac MRI Market, by Region, 2021-2023 (USD Million)
Table 37 Cardiac MRI Market, by Region, 2024-2029 (USD Million)
Table 38 Nuclear Cardiology Systems Market, by Region, 2021-2023 (USD Million)
Table 39 Nuclear Cardiology Systems Market, by Region, 2024-2029 (USD Million)
Table 40 Cardiac Diagnostic Catheters Market, by Region, 2021-2023 (USD Million)
Table 41 Cardiac Diagnostic Catheters Market, by Region, 2024-2029 (USD Million)
Table 42 Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 43 Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 44 Cardiac Rhythm Management Devices Market, by Region, 2021-2023 (USD Million)
Table 45 Cardiac Rhythm Management Devices Market, by Region, 2024-2029 (USD Million)
Table 46 Cardiovascular Devices Market: List of Companies with Key Products
Table 47 Pacemakers Market, by Region, 2021-2023 (USD Million)
Table 48 Pacemakers Market, by Region, 2024-2029 (USD Million)
Table 49 Implantable Cardioverter Defibrillators Market, by Region, 2021-2023 (USD Million)
Table 50 Implantable Cardioverter Defibrillators Market, by Region, 2024-2029 (USD Million)
Table 51 Cardiac Resynchronization Therapy Devices Market, by Region, 2021-2023 (USD Million)
Table 52 Cardiac Resynchronization Therapy Devices Market, by Region, 2024-2029 (USD Million)
Table 53 Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 54 Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 55 Interventional Cardiology Devices Market, by Region, 2021-2023 (USD Million)
Table 56 Interventional Cardiology Devices Market, by Region, 2024-2029 (USD Million)
Table 57 Coronary Stents Market, by Region, 2021-2023 (USD Million)
Table 58 Coronary Stents Market, by Region, 2024-2029 (USD Million)
Table 59 Heart Valve Devices Market, by Region, 2021-2023 (USD Million)
Table 60 Heart Valve Devices Market, by Region, 2024-2029 (USD Million)
Table 61 Closure Devices Market, by Region, 2021-2023 (USD Million)
Table 62 Closure Devices Market, by Region, 2024-2029 (USD Million)
Table 63 Surgical Catheters Market, by Region, 2021-2023 (USD Million)
Table 64 Surgical Catheters Market, by Region, 2024-2029 (USD Million)
Table 65 Guidewires Market, by Region, 2021-2023 (USD Million)
Table 66 Guidewires Market, by Region, 2024-2029 (USD Million)
Table 67 Other Interventional Cardiology Devices Market, by Region, 2021-2023 (USD Million)
Table 68 Other Interventional Cardiology Devices Market, by Region, 2024-2029 (USD Million)
Table 69 Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 70 Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 71 Cardiac Assist Devices Market, by Region, 2021-2023 (USD Million)
Table 72 Cardiac Assist Devices Market, by Region, 2024-2029 (USD Million)
Table 73 Ventricular Assist Devices Market, by Region, 2021-2023 (USD Million)
Table 74 Ventricular Assist Devices Market, by Region, 2024-2029 (USD Million)
Table 75 Intra-Aortic Balloon Pumps Market, by Region, 2021-2023 (USD Million)
Table 76 Intra-Aortic Balloon Pumps Market, by Region, 2024-2029 (USD Million)
Table 77 Total Artificial Heart Market, by Region, 2021-2023 (USD Million)
Table 78 Total Artificial Heart Market, by Region, 2024-2029 (USD Million)
Table 79 Impella Devices Market, by Region, 2021-2023 (USD Million)
Table 80 Impella Devices Market, by Region, 2024-2029 (USD Million)
Table 81 Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 82 Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 83 Electrophysiology Devices Market, by Region, 2021-2023 (USD Million)
Table 84 Electrophysiology Devices Market, by Region, 2024-2029 (USD Million)
Table 85 Ep Catheters Market, by Region, 2021-2023 (USD Million)
Table 86 Ep Catheters Market, by Region, 2024-2029 (USD Million)
Table 87 Ablation Systems Market, by Region, 2021-2023 (USD Million)
Table 88 Ablation Systems Market, by Region, 2024-2029 (USD Million)
Table 89 3D Mapping Systems Market, by Region, 2021-2023 (USD Million)
Table 90 3D Mapping Systems Market, by Region, 2024-2029 (USD Million)
Table 91 External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 92 External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 93 External Support Devices Market, by Region, 2021-2023 (USD Million)
Table 94 External Support Devices Market, by Region, 2024-2029 (USD Million)
Table 95 External Defibrillators Market, by Region, 2021-2023 (USD Million)
Table 96 External Defibrillators Market, by Region, 2024-2029 (USD Million)
Table 97 External Pacemakers Market, by Region, 2021-2023 (USD Million)
Table 98 External Pacemakers Market, by Region, 2024-2029 (USD Million)
Table 99 Cardiac Compression Devices Market, by Region, 2021-2023 (USD Million)
Table 100 Cardiac Compression Devices Market, by Region, 2024-2029 (USD Million)
Table 101 Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 102 Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 103 Cardiovascular Monitoring Devices Market, by Region, 2021-2023 (USD Million)
Table 104 Cardiovascular Monitoring Devices Market, by Region, 2024-2029 (USD Million)
Table 105 Blood Pressure Monitors Market, by Region, 2021-2023 (USD Million)
Table 106 Blood Pressure Monitors Market, by Region, 2024-2029 (USD Million)
Table 107 Pulse Oximeters Market, by Region, 2021-2023 (USD Million)
Table 108 Pulse Oximeters Market, by Region, 2024-2029 (USD Million)
Table 109 Implantable Cardiac Monitors Market, by Region, 2021-2023 (USD Million)
Table 110 Implantable Cardiac Monitors Market, by Region, 2024-2029 (USD Million)
Table 111 Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 112 Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 113 Coronary Artery Disease Market, by Type, 2021-2023 (USD Million)
Table 114 Coronary Artery Disease Market, by Type, 2024-2029 (USD Million)
Table 115 Coronary Artery Disease Market, by Region, 2021-2023 (USD Million)
Table 116 Coronary Artery Disease Market, by Region, 2024-2029 (USD Million)
Table 117 Coronary Artery Disease Market for Angina Pectoris, by Region, 2021-2023 (USD Million)
Table 118 Coronary Artery Disease Market for Angina Pectoris, by Region, 2024-2029 (USD Million)
Table 119 Coronary Artery Disease Market for Myocardial Infraction, by Region, 2021-2023 (USD Million)
Table 120 Coronary Artery Disease Market for Myocardial Infraction, by Region, 2024-2029 (USD Million)
Table 121 Arrhythmias Market, by Type, 2021-2023 (USD Million)
Table 122 Arrhythmias Market, by Type, 2024-2029 (USD Million)
Table 123 Arrhythmias Market, by Region, 2021-2023 (USD Million)
Table 124 Arrhythmias Market, by Region, 2024-2029 (USD Million)
Table 125 Arrhythmias Market for Tachycardia, by Region, 2021-2023 (USD Million)
Table 126 Arrhythmias Market for Tachycardia, by Region, 2024-2029 (USD Million)
Table 127 Arrhythmias Market for Bradycardia, by Region, 2021-2023 (USD Million)
Table 128 Arrhythmias Market for Bradycardia, by Region, 2024-2029 (USD Million)
Table 129 Structural Heart Disease Market, by Type, 2021-2023 (USD Million)
Table 130 Structural Heart Disease Market, by Type, 2024-2029 (USD Million)
Table 131 Structural Heart Disease Market, by Region, 2021-2023 (USD Million)
Table 132 Structural Heart Disease Market, by Region, 2024-2029 (USD Million)
Table 133 Valvular Heart Disease Market, by Region, 2021-2023 (USD Million)
Table 134 Valvular Heart Disease Market, by Region, 2024-2029 (USD Million)
Table 135 Congenital Heart Disease Market, by Region, 2021-2023 (USD Million)
Table 136 Congenital Heart Disease Market, by Region, 2024-2029 (USD Million)
Table 137 Cardiomyopathy Market, by Region, 2021-2023 (USD Million)
Table 138 Cardiomyopathy Market, by Region, 2024-2029 (USD Million)
Table 139 Congestive Heart Failure Market, by Region, 2021-2023 (USD Million)
Table 140 Congestive Heart Failure Market, by Region, 2024-2029 (USD Million)
Table 141 Inflammatory Heart Disease Market, by Type, 2021-2023 (USD Million)
Table 142 Inflammatory Heart Disease Market, by Type, 2024-2029 (USD Million)
Table 143 Inflammatory Heart Disease Market, by Region, 2021-2023 (USD Million)
Table 144 Inflammatory Heart Disease Market, by Region, 2024-2029 (USD Million)
Table 145 Inflammatory Heart Disease Market for Pericarditis, by Region, 2021-2023 (USD Million)
Table 146 Inflammatory Heart Disease Market for Pericarditis, by Region, 2024-2029 (USD Million)
Table 147 Inflammatory Heart Disease Market for Myocarditis, by Region, 2021-2023 (USD Million)
Table 148 Inflammatory Heart Disease Market for Myocarditis, by Region, 2024-2029 (USD Million)
Table 149 Inflammatory Heart Disease Market for Endocarditis, by Region, 2021-2023 (USD Million)
Table 150 Inflammatory Heart Disease Market for Endocarditis, by Region, 2024-2029 (USD Million)
Table 151 Other Cardiovascular Indications Market, by Region, 2021-2023 (USD Million)
Table 152 Other Cardiovascular Indications Market, by Region, 2024-2029 (USD Million)
Table 153 Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 154 Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 155 Cardiovascular Devices Market for Hospitals & Clinics, by Region, 2021-2023 (USD Million)
Table 156 Cardiovascular Devices Market for Hospitals & Clinics, by Region, 2024-2029 (USD Million)
Table 157 Cardiovascular Devices Market for Diagnostic Laboratories, by Region, 2021-2023 (USD Million)
Table 158 Cardiovascular Devices Market for Diagnostic Laboratories, by Region, 2024-2029 (USD Million)
Table 159 Cardiovascular Devices Market for Ambulatory Surgery Centers, by Region, 2021-2023 (USD Million)
Table 160 Cardiovascular Devices Market for Ambulatory Surgery Centers, by Region, 2024-2029 (USD Million)
Table 161 Cardiovascular Devices Market for Other End-users, by Region, 2021-2023 (USD Million)
Table 162 Cardiovascular Devices Market for Other End-users, by Region, 2024-2029 (USD Million)
Table 163 Cardiovascular Devices Market, by Region, 2021-2023 (USD Million)
Table 164 Cardiovascular Devices Market, by Region, 2024-2029 (USD Million)
Table 165 North America: Cardiovascular Devices Market, by Country, 2021-2023 (USD Million)
Table 166 North America: Cardiovascular Devices Market, by Country, 2024-2029 (USD Million)
Table 167 North America: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 168 North America: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 169 North America: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 170 North America: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 171 North America: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 172 North America: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 173 North America: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (Thousand Units)
Table 174 North America: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (Thousand Units)
Table 175 North America: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 176 North America: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 177 North America: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 178 North America: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 179 North America: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 180 North America: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 181 North America: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 182 North America: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 183 North America: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 184 North America: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 185 North America: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (Thousand Units)
Table 186 North America: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (Thousand Units)
Table 187 North America: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 188 North America: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 189 North America: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 190 North America: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 191 North America: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 192 North America: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 193 North America: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 194 North America: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 195 North America: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 196 North America: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 197 North America: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 198 North America: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 199 US: Key Macroindicators
Table 200 US: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 201 US: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 202 US: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 203 US: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 204 US: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 205 US: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 206 US: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 207 US: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 208 US: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 209 US: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 210 US: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 211 US: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 212 US: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 213 US: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 214 US: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 215 US: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 216 US: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 217 US: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 218 US: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 219 US: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 220 US: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 221 US: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 222 US: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 223 US: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 224 US: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 225 US: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 226 US: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 227 US: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 228 Canada: Key Macroindicators
Table 229 Canada: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 230 Canada: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 231 Canada: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 232 Canada: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 233 Canada: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 234 Canada: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 235 Canada: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 236 Canada: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 237 Canada: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 238 Canada: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 239 Canada: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 240 Canada: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 241 Canada: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 242 Canada: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 243 Canada: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 244 Canada: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 245 Canada: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 246 Canada: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 247 Canada: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 248 Canada: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 249 Canada: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 250 Canada: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 251 Canada: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 252 Canada: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 253 Canada: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 254 Canada: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 255 Canada: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 256 Canada: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 257 Europe: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 258 Europe: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 259 Europe: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 260 Europe: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 261 Europe: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 262 Europe: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 263 Europe: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (Thousand Units)
Table 264 Europe: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (Thousand Units)
Table 265 Europe: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 266 Europe: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 267 Europe: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 268 Europe: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 269 Europe: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 270 Europe: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 271 Europe: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 272 Europe: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 273 Europe: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 274 Europe: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 275 Europe: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (Thousand Units)
Table 276 Europe: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (Thousand Units)
Table 277 Europe: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 278 Europe: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 279 Europe: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 280 Europe: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 281 Europe: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 282 Europe: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 283 Europe: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 284 Europe: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 285 Europe: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 286 Europe: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 287 Europe: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 288 Europe: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 289 Asia-Pacific: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 290 Asia-Pacific: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 291 Asia-Pacific: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 292 Asia-Pacific: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 293 Asia-Pacific: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 294 Asia-Pacific: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 295 Asia-Pacific: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (Thousand Units)
Table 296 Asia-Pacific: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (Thousand Units)
Table 297 Asia-Pacific: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 298 Asia-Pacific: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 299 Asia-Pacific: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 300 Asia-Pacific: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 301 Asia-Pacific: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 302 Asia-Pacific: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 303 Asia-Pacific: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 304 Asia-Pacific: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 305 Asia-Pacific: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 306 Asia-Pacific: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 307 Asia-Pacific: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (Thousand Units)
Table 308 Asia-Pacific: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (Thousand Units)
Table 309 Asia-Pacific: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 310 Asia-Pacific: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 311 Asia-Pacific: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 312 Asia-Pacific: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 313 Asia-Pacific: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 314 Asia-Pacific: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 315 Asia-Pacific: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 316 Asia-Pacific: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 317 Asia-Pacific: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 318 Asia-Pacific: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 319 Asia-Pacific: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 320 Asia-Pacific: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 321 Latin America: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 322 Latin America: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 323 Latin America: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 324 Latin America: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 325 Latin America: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 326 Latin America: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 327 Latin America: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (Thousand Units)
Table 328 Latin America: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (Thousand Units)
Table 329 Latin America: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 330 Latin America: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 331 Latin America: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 332 Latin America: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 333 Latin America: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 334 Latin America: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 335 Latin America: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 336 Latin America: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 337 Latin America: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 338 Latin America: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 339 Latin America: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (Thousand Units)
Table 340 Latin America: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (Thousand Units)
Table 341 Latin America: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 342 Latin America: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 343 Latin America: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 344 Latin America: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 345 Latin America: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 346 Latin America: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 347 Latin America: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 348 Latin America: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 349 Latin America: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 350 Latin America: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 351 Latin America: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 352 Latin America: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 353 Middle East & Africa: Cardiovascular Devices Market, by Product, 2021-2023 (USD Million)
Table 354 Middle East & Africa: Cardiovascular Devices Market, by Product, 2024-2029 (USD Million)
Table 355 Middle East & Africa: Cardiac Imaging & Diagnostic Devices Market, by Type, 2021-2023 (USD Million)
Table 356 Middle East & Africa: Cardiac Imaging & Diagnostic Devices Market, by Type, 2024-2029 (USD Million)
Table 357 Middle East & Africa: Cardiac Rhythm Management Devices Market, by Type, 2021-2023 (USD Million)
Table 358 Middle East & Africa: Cardiac Rhythm Management Devices Market, by Type, 2024-2029 (USD Million)
Table 359 Middle East & Africa: Cardiovascular Devices Market, by Cardiac Rhythm Management Devices, 2021-2023 (Thousand Units)
Table 360 Middle East & Africa: Cardiovascular Devices Market, by Cardiac Rhythm Management Devices, 2024-2029 (Thousand Units)
Table 361 Middle East & Africa: Interventional Cardiology Devices Market, by Type, 2021-2023 (USD Million)
Table 362 Middle East & Africa: Interventional Cardiology Devices Market, by Type, 2024-2029 (USD Million)
Table 363 Middle East & Africa: Cardiac Assist Devices Market, by Type, 2021-2023 (USD Million)
Table 364 Middle East & Africa: Cardiac Assist Devices Market, by Type, 2024-2029 (USD Million)
Table 365 Middle East & Africa: Electrophysiology Devices Market, by Type, 2021-2023 (USD Million)
Table 366 Middle East & Africa: Electrophysiology Devices Market, by Type, 2024-2029 (USD Million)
Table 367 Middle East & Africa: External Support Devices Market, by Type, 2021-2023 (USD Million)
Table 368 Middle East & Africa: External Support Devices Market, by Type, 2024-2029 (USD Million)
Table 369 Middle East & Africa: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (USD Million)
Table 370 Middle East & Africa: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (USD Million)
Table 371 Middle East & Africa: Cardiovascular Monitoring Devices Market, by Type, 2021-2023 (Thousand Units)
Table 372 Middle East & Africa: Cardiovascular Monitoring Devices Market, by Type, 2024-2029 (Thousand Units)
Table 373 Middle East & Africa: Cardiovascular Devices Market, by Indication, 2021-2023 (USD Million)
Table 374 Middle East & Africa: Cardiovascular Devices Market, by Indication, 2024-2029 (USD Million)
Table 375 Middle East & Africa: Coronary Artery Disease Market, by Indication, 2021-2023 (USD Million)
Table 376 Middle East & Africa: Coronary Artery Disease Market, by Indication, 2024-2029 (USD Million)
Table 377 Middle East & Africa: Arrhythmias Market, by Indication, 2021-2023 (USD Million)
Table 378 Middle East & Africa: Arrhythmias Market, by Indication, 2024-2029 (USD Million)
Table 379 Middle East & Africa: Structural Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 380 Middle East & Africa: Structural Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 381 Middle East & Africa: Inflammatory Heart Disease Market, by Indication, 2021-2023 (USD Million)
Table 382 Middle East & Africa: Inflammatory Heart Disease Market, by Indication, 2024-2029 (USD Million)
Table 383 Middle East & Africa: Cardiovascular Devices Market, by End-user, 2021-2023 (USD Million)
Table 384 Middle East & Africa: Cardiovascular Devices Market, by End-user, 2024-2029 (USD Million)
Table 385 Overview of Strategies Deployed by Key Manufacturing Companies
Table 386 Cardiovascular Devices Market: Degree of Competition
Table 387 Cardiovascular Devices Market: Region Footprint
Table 388 Cardiovascular Market: Product Footprint
Table 389 Cardiovascular Devices Market: Indication Footprint
Table 390 Cardiovascular Devices Market: End-user Footprint
Table 391 Cardiovascular Devices Market: Detailed List of Key Startup/SME Players
Table 392 Cardiovascular Devices Market: Competitive Benchmarking of Key Emerging Players/Startups, by Region
Table 393 Cardiovascular Devices Market: Product Launches & Approvals, January 2021-November 2024
Table 394 Cardiovascular Devices Market: Deals, January 2021-November 2024
Table 395 Cardiovascular Devices Market: Expansions, January 2021-November 2024
Table 396 Cardiovascular Devices Market: Other Developments, January 2021-November 2024
Table 397 Medtronic: Company Overview
Table 398 Medtronic: Products Offered
Table 399 Medtronic: Product Launches & Approvals, January 2021-November 2024
Table 400 Medtronic: Deals, January 2021-November 2024
Table 401 Abbott Laboratories: Company Overview
Table 402 Abbott Laboratories: Products Offered
Table 403 Abbott Laboratories: Product Launches & Approvals, January 2021-November 2024
Table 404 Abbott Laboratories: Deals, January 2021-November 2024
Table 405 Boston Scientific Corporation.: Company Overview
Table 406 Boston Scientific Corporation.: Products Offered
Table 407 Boston Scientific Corporation: Product Launches & Approvals, January 2021-November 2024
Table 408 Boston Scientific Corporation: Deals, January 2021-November 2024
Table 409 GE Healthcare: Company Overview
Table 410 GE Healthcare: Products Offered
Table 411 GE Healthcare: Product Launches & Approvals, January 2021-November 2024
Table 412 GE Healthcare: Deals, January 2021-November 2024
Table 413 Terumo Corporation: Company Overview
Table 414 Terumo Corporation: Products Offered
Table 415 Terumo Corporation: Product Launches & Approvals, January 2021-November 2024
Table 416 Edwards Lifesciences Corporation: Company Overview
Table 417 Edwards Lifesciences Corporation: Products Offered
Table 418 Edwards Lifesciences Corporation: Product Launches & Approvals, January 2021-November 2024
Table 419 Edward Lifesciences Corporation: Deals, January 2021-November 2024
Table 420 Siemens Healthineers AG: Company Overview
Table 421 Siemens Healthineers AG: Products Offered
Table 422 Siemens Healthineers AG: Product Launches & Approvals, January 2021-November 2024
Table 423 Johnson and Johnson Services, Inc.: Company Overview
Table 424 Johnson and Johnson Services, Inc.: Products Offered
Table 425 Johnson and Johnson Services Inc.: Product Launches & Approvals, January 20210-November 2024
Table 426 Johnson and Johnson Services, Inc.: Deals, January 2021-November 2024
Table 427 Sahajanand Medical Technologies Limited: Company Overview
Table 428 Sahajanand Medical Technologies Limited: Products Offered
Table 429 Baxter Intenational, Inc.: Company Overview
Table 430 Baxter International, Inc.: Products Offered
Table 431 Baxter International Inc.: Deals, January 2021-November 2024
Table 432 Artivion, Inc.: Company Overview
Table 433 Artivion, Inc.: Products Offered
Table 434 Getinge Ab: Company Overview
Table 435 Getinge Ab: Products Offered
Table 436 Getinge Ab: Product Launches & Approvals, January 2021-November 2024
Table 437 Getinge Ab: Deals, January 2021-March 2024
Table 438 Koninklijke Philips N.V.: Company Overview
Table 439 Koninklijke Philips N.V.: Products Offered
Table 440 Koninklijke Philips N.V.: Product Launches & Approvals, January 2021-November 2024
Table 441 Nihon Kohden Corporation: Company Overview
Table 442 Nihon Kohden Corporation: Products Offered
Table 443 Biotronik SE & Co.KG.: Company Overview
Table 444 Biotronik SE & Co.KG: Products Offered
Table 445 Lepu Medical Technology (Beijing) Co. Ltd.: Company Overview
Table 446 Lepu Medical Technology (Beijing) Co. Ltd.: Products Offered
Table 447 Lepu Medical Technology (Beijing) Co. Ltd.:: Product Launches & Approvals, January 2021-November 2024
Table 448 Microport Scientific Corporation: Company Overview
Table 449 Microport Scientific Corporation: Products Offered
Table 450 Microport Scientific Corporation: Product Launches & Approvals, January 2021-November 2024
Table 451 Angiodynamics Inc.: Company Overview
Table 452 Angiodynamics Inc.: Products Offered
Table 453 Japan Lifeline Co. Ltd.: Company Overview
Table 454 Japan Lifeline Co. Ltd.Products Offered
Table 455 Japan Lifeline Co. Ltd.: Product Launches & Approvals, January 2021-November 2024
Table 456 W.L. Gore & Associates: Company Overview
Table 457 W.L. Gore & Associates: Products Offered
Table 458 B. Braun SE: Company Overview
Table 459 B. Braun SE.: Products Offered

Figure 1 Markets & Regions Covered
Figure 2 Research Design
Figure 3 Primary Sources
Figure 4 Primary Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 5 Market Size Approach: Revenue Share Analysis
Figure 6 Top-Down Approach
Figure 7 Impact Analysis of Drivers, Restraints, Opportunities, and Challenges (2024-2029)
Figure 8 Cardiovascular Devices Market: CAGR Projections
Figure 9 Data Triangulation Methodology
Figure 10 Cardiovascular Devices Market, by Product, 2024 vs. 2029 (USD Million)
Figure 11 Cardiac Imaging & Diagnostic Devices Market, by Type, 2024 vs. 2029 (USD Million)
Figure 12 Cardiovascular Devices Market, by Indication, 2024 vs. 2029 (USD Million)
Figure 13 Cardiovascular Devices Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 14 Geographic Snapshot of Cardiovascular Devices Market
Figure 15 Increasing Prevalence of Cardiovascular Diseases to Propel Market
Figure 16 Hospitals & Clinics Segment Accounted for Largest Market Share in 2023
Figure 17 Asia-Pacific to Grow at Highest CAGR During Forecast Period
Figure 18 Cardiovascular Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Leading Trends
Figure 20 Cardiovascular Devices Market: Porter's Five Forces Analysis
Figure 21 Number of Patents Published (January 2014-September 2024)
Figure 22 Top Applicants (Companies/Institutions) for Cardiovascular Devices Patents (January 2014-September 2024)
Figure 23 Top Applicant Countries/Regions for Cardiovascular Devices (January 2014- July 2024)
Figure 24 Influence of Stakeholders on Buying Process for Cardiovascular Devices
Figure 25 Key Buying Criteria for Top 3 End-users of Cardiovascular Devices
Figure 26 Cardiovascular Devices Market: Ecosystem Analysis
Figure 27 Cardiovascular Devices Market: Supply Chain Analysis
Figure 28 Revenue Shift for Cardiovascular Devices Market
Figure 29 Cardiovascular Devices Market: Investment & Funding Scenario (2018-2022)
Figure 30 Cardiovascular Devices Market: Geographic Snapshot
Figure 31 North America: Cardiovascular Devices Market Snapshot
Figure 32 Revenue Analysis of Key Players in Cardiovascular Devices Market (2021-2023)
Figure 33 Market Share Analysis of Key Players in Cardiovascular Devices Market (2023)
Figure 34 Ranking of Key Players in Cardiovascular Devices Market, 2023
Figure 35 Cardiovascular Devices Market: Company Evaluation Matrix (Key Players), 2023
Figure 36 Cardiovascular Devices Market: Company Footprint
Figure 37 Cardiovascular Devices Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 38 Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors
Figure 39 EV/EBITDA of Key Vendors
Figure 40 Cardiovascular Devices Market: Brand/Product Comparative Analysis
Figure 41 Medtronic: Company Snapshot (2024)
Figure 42 Abbott Laboratories: Company Snapshot (2023)
Figure 43 Boston Scientific Corporation: Company Snapshot (2023)
Figure 44 GE Healthcare: Company Snapshot (2023)
Figure 45 Terumo Corporation: Company Snapshot (2023)
Figure 46 Edwards Lifesciences Corporation: Company Snapshot (2023)
Figure 47 Siemens Healthineers AG: Company Snapshot (2023)
Figure 48 Johnson and Johnson Services, Inc.: Company Snapshot (2023)
Figure 49 Baxter Intenational, Inc.: Company Snapshot (2023)
Figure 50 Artivion, Inc.: Company Snapshot (2023)
Figure 51 Getinge Ab: Company Snapshot (2023)
Figure 52 Koninklijke Philips N.V.: Company Snapshot (2023)
Figure 53 Nihon Kohden Corporation: Company Snapshot (2023)
Figure 54 Microport Scientific Corporation.: Company Snapshot (2023)
Figure 55 Angiodynamics Inc.: Company Snapshot (2023)
Figure 56 Japan Lifeline Co. Ltd.: Company Snapshot (2023)
Figure 57 B. Braun SE: Company Snapshot (2023)